Midgard Science
TP

Teva Pharmaceuticals

Macquarie Park, Australia tevapharm.com From their website, Nov 2026

Work here? Claim this listing

About

Teva Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and commercializes medicines for patients in 57 markets. Its work spans generic medicines, biosimilars, innovative medicines, and research programs focused on neuroscience, immunology, respiratory conditions, central nervous system disorders, and oncology.

Services

  • Generic medicines development

    Develops generic medicines designed to match branded drugs in active ingredients, strength, dosage form, safety, quality, efficacy, and clinical effect.

  • Generic medicines regulation

    Supports the regulatory approval process for generic medicines across different regions and countries.

  • Generic medicines out-licensing

    Out-licenses a portfolio of generic pharmaceuticals and provides registration dossiers and launch support through Medis.

  • Biosimilar medicines development and manufacturing

    Develops and manufactures biosimilars and supports their global delivery and commercialization.

  • Collaborative research and investigator-sponsored studies

    Accepts investigator study requests through a submission management system and reviews submissions for completion, clarity, and compliance.

  • Clinical development

    Supports the stages of clinical development, including discovery, optimization, in vivo testing, toxicology, and clinical trials.

  • Product quality complaint handling

    Provides a form for reporting product quality concerns for selected products.

  • Research and development

    Advances drug discovery and development using scientific expertise and emerging technologies.

8 more services
  • Innovative medicines development
  • Generic medicines
  • Biologics development
  • Biologics manufacturing
  • Antibody discovery
  • Bioanalysis
  • Clinical biomarkers
  • Drug product tech transfer
Turnaround
  • Registration should take about 10 minutes to complete.
  • 4 minutes
  • 6 Minutes
  • 8 Minutes
  • 5 Minutes

Capabilities

Assays and studies
  • Bioanalysis
  • Antibodies
  • Chemical and in vitro biological systems
  • Toxicology studies
  • Drug metabolism studies
  • Bioequivalence studies
4 more
  • Interventional clinical trials
  • Observational studies
  • Expanded access studies
  • Clinical biomarkers
Scale and capacity
  • Approximately 37,000 employees
  • 57 markets
  • More than 30 biosimilar products approved or in development
  • 7 biosimilars launched since 2020
  • 15 biosimilars in market
  • 16 biosimilar products in the pipeline
3 more
  • 185+ pharmaceutical products
  • 140+ countries
  • More than 1,160 generic products in its development pipeline
Therapeutic areas
  • Neuroscience
  • Immunology
  • Respiratory conditions
  • Central nervous system
  • Oncology
  • Schizophrenia
6 more
  • Bipolar disorder
  • Tourette syndrome
  • ADHD
  • Huntington's disease
  • Common diseases
  • Rare diseases

Modalities and species

Modalities
  • Antibody
  • Biosimilar
Species and models
  • In vivo animal disease models
  • Healthy participants

Industries served

  • Pharmaceuticals
  • Biopharmaceuticals
  • Healthcare

Company

Type
Manufacturer
Founded
1901
Size
5001+ employees
Quality
Rigorous regulatory evaluation (biosimilars) · same quality standards (generic drugs) · bioequivalent (generic drugs)

Locations

Based in
Macquarie Park, Australia
Sites
  • Netanya, Israel
  • Ulm, Germany
  • Philadelphia, USA
Serves
Worldwide, Europe, North America, International markets, 57 markets worldwide

Public records

Parent company
TEVA PHARMACEUTICALS FINANCE NETHERLANDS B.V. · NL GLEIF
FDA drug establishment registration
2245641 · ANALYSIS; LABEL; MANUFACTURE; PACK source
Wikidata
Q898750 source

Similar labs